Understanding cancer’s molecular makeup is crucial for tailoring effective and precision treatments. At ‘AEGLE OMICS,’ we utilize cutting-edge technologies for biomarker identification, enabling our medical teams to comprehensively understand tumor biology. With advancements in cancer therapy, oncologists now prioritize molecular profiling to devise personalized treatment strategies. Regardless of tumor location, analyzing its molecular composition provides insights into cancer behavior and guides treatment selection for optimal outcomes.”
Our vision
AEGLE OMICS plays a crucial role in healthcare, providing vital insights into an individual’s genes, disease risks, and treatment options. We assist patients in sending their cancer samples and blood to specialized labs abroad for precise gene testing. By focusing on established gene issues, we streamline testing and reduce unnecessary costs. Additionally, our dedication to affordability ensures that more people can access high-quality genomic testing without compromising accuracy.
Our mission
Our mission is to provide the most versatile access to genomic testing to our patients and to our medical oncologists, radiation oncologists, hematologists, pathologists, and molecular biologists. We offer the best interpretations, focusing on the most precise pathogenic mutations that represent actionable targets for treatment.
Meet Our Lead Consultants Team
DR. MAHENDRA PERERA
MBBS, MD, Dip.RT, FSLCO
Chairman / Director
Dr. Mahendra Perera, Chairman of ‘AEGLE OMICS (Pvt) Ltd,’ brings 20 years of expertise in Clinical Oncology, Radiotherapy, genetics, and molecular biology. His groundbreaking research and strategic vision drives advancements in personalized medicine and genetic diagnostics, revolutionizing healthcare through innovation and compassion. His groundbreaking research and strategic vision drives advancements in personalized medicine and genetic diagnostics, revolutionizing healthcare through innovation and compassion.
THIVANKA R. PERERA
BFA (Hon) Motion Picture & TV (USA)
Executive Director / Financial Investor
Thivanka Rukshan Perera, an esteemed investor and facility provider for AEGLE OMICS Pvt Ltd, brings expertise from his acclaimed career as an international documentary filmmaker. Thivanka’s involvement underscores our commitment to innovation and success in genomic testing. We’re honored to have him on board as we strive for excellence together.
AMILA K. HERATH
MBA, PhD (UK),
General Manager – Aegle Omics
Amila Herath, Executive Director at AEGLE Omics, brings extensive experience from the pharmaceutical industry, specializing in top-tier procurement services for international trade. As an Executive Director, he guides our strategic direction, leveraging industry knowledge and networks to propel us forward as leaders in genomic testing and healthcare innovation.
DEVENDRA RAJATHEVAR
MBA (UK),
Dip Sales & Marketing (India) Dip.IB (SAQ).
Manager – Business Development
Devendra is a pioneer in genomic testing, notably in Sri Lanka and India, where he’s instrumental in establishing facilities and partnerships with international labs. As Business Development Manager, Devendra’s strategic vision and network drive AEGLE Omics’ growth. His knack for identifying opportunities and navigating healthcare landscapes positions us for continued success in genomics.
Contact our experienced cancer team
We are happy to advise you or help you to book a consultation with any Cancer Specialist to discuss your options of precision cancer treatment.